Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.
about
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes.The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.Pharmacological Properties of Faster-Acting Insulin Aspart.Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.
P2860
Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Faster-acting insulin aspart p ...... with type 1 diabetes mellitus.
@en
type
label
Faster-acting insulin aspart p ...... with type 1 diabetes mellitus.
@en
prefLabel
Faster-acting insulin aspart p ...... with type 1 diabetes mellitus.
@en
P2093
P2860
P356
P1433
P1476
Faster-acting insulin aspart p ...... with type 1 diabetes mellitus.
@en
P2093
Hanne Haahr
Lars Erichsen
Maryam Fath
Olga Kordonouri
P2860
P356
10.1111/PEDI.12506
P577
2017-02-06T00:00:00Z